Find uplifting stories about heroes, innovations, and solutions
2544 results for "obesity drugs"
A new class of medications is transforming obesity treatment by working with the body's hunger signals rather than against them, helping patients lose up to 30% of their body weight. These GLP-1 drugs are proving that obesity has deep biological roots beyond willpower alone.
A groundbreaking trial found that semaglutide, the popular weight loss drug, significantly reduced alcohol cravings and heavy drinking days in people battling both obesity and alcohol addiction. The discovery could transform treatment options for millions worldwide struggling with alcohol use disorder.
A drug that flopped in Alzheimer's trials just helped obese mice lose 20% of their body weight without eating less or exercising more. Johns Hopkins researchers are now testing whether this accidental discovery could help millions of people struggling with severe obesity.
A breakthrough obesity treatment helped patients lose nearly 30% of their body weight—results previously only achievable through surgery. The experimental drug could transform how millions manage obesity while Medicare makes these treatments more affordable.
New research reveals genetic variants that explain why weight-loss drugs like semaglutide help some people lose 25% of their body weight while others see minimal results. The discovery could pave the way for more personalized treatments.
A new experimental obesity treatment targeting three hormones has shown significant weight loss in early testing. The "triple-G" drug from Kailera offers fresh hope in the rapidly expanding field of weight management medicine.
Eli Lilly's new obesity medication helped people with diabetes achieve significant weight loss and better blood sugar control, a notoriously difficult combination to achieve. While researchers are monitoring some cardiac events, the drug represents a major step forward for millions struggling with both conditions.
Eli Lilly is building a $3.5 billion manufacturing facility in Pennsylvania to produce breakthrough obesity treatments, including an experimental drug showing record-breaking weight loss results. The plant will create 850 permanent jobs and 2,000 construction positions when it opens in 2031.
More than 10 million Americans just regained insurance coverage for a life-changing obesity treatment after CVS reversed its restrictions on Zepbound. The win came after drugmaker Eli Lilly slashed prices to make the medication more accessible.
Scientists created a "Trojan horse" drug that delivers double the weight loss power by sneaking extra metabolism boosters directly into cells. Early tests in mice showed stronger results than current treatments, with fewer side effects because it works only where needed.
France just became the first EU country to cover breakthrough obesity medications for severely obese patients, helping one million people access treatments that previously cost €300 per month. The bold public health move recognizes obesity as a serious medical condition deserving national support.
%2Ffile%2Fattachments%2F2992%2F13971407_975900.jpg)
Starting mid-June, France becomes the first EU nation to reimburse life-changing weight-loss medications for severely obese patients. Up to one million people could access treatments that currently cost €300 monthly out of pocket.
A new obesity treatment from pharmaceutical company Boehringer has shown promising results, helping patients lose an average of 16.6% of their body weight in clinical trials. The breakthrough adds another tool to the growing arsenal of effective weight loss medications changing lives worldwide.
A new obesity treatment that only requires monthly injections continues to show promising results, offering hope for easier weight loss options. Patients in a recent study lost over 12% of their body weight without hitting a plateau.
Eli Lilly just made its weight loss drug Zepbound more affordable for millions of workers by letting employers chip in on the cost. Instead of charging insurance prices, they're offering it at $449 a month with flexible employer subsidies.
Doctors are discovering why weight-loss drugs work brilliantly for some people but fail for others. The answer could revolutionize how we treat obesity within just a few years.
A massive study of 600,000 veterans found that GLP-1 medications, commonly prescribed for weight loss and diabetes, cut addiction death rates in half. The drugs also reduced the risk of developing substance abuse problems by up to 25% across multiple substances.
People taking obesity medications like Ozempic and Wegovy report a surprising benefit: the constant mental chatter about food has completely disappeared. Scientists think this discovery could unlock the mystery of what causes obesity.
Scientists discovered a molecule from python blood that helps obese mice lose 9% of their weight in 28 days, without the stomach problems linked to current obesity drugs. The breakthrough could lead to a new generation of weight-loss treatments inspired by how pythons digest massive meals.
A groundbreaking obesity medication helped people lose an average of 70 pounds in clinical trials, matching results previously only seen with bariatric surgery. The drug offers new hope for millions struggling with obesity and related health conditions.
Showing 20 of 2544